8/27/2010

AquaBounty Technologies has taken the initial steps to seek approval in Canada for its biotech salmon as it awaits an FDA panel's review of the product. AquaBounty President and CEO Ronald Stotish said the Canadian application is in its early stages, but the company is "very interested because of our strong presence" in the country.

Related Summaries